EUVIMEDEUVIMED entdecken
Crossref

The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia

Ali A El-Solh, Yolanda Lawson, Gregory E Wilding

Sleep Health · 2023

DOI: 10.1016/j.sleh.2023.05.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep Health, 2023. Verfasst von Ali A El-Solh und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Veterans Affairs Western New York Healthcare System, Western New York Respiratory Research Center, Division of Pulmonary, Critical Care, and Slee…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Hypnotics and Sedatives, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: CSRD VA, Office of Research and Development, Health Services Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To examine whether hypnotic use in patients with insomnia reduces major adverse cardiovascular events, including all-cause mortality and nonfatal major adverse cardiovascular events. METHODS: Using the Veterans Affairs Corporate Data Warehouse, we conducted a retrospective cohort study of 16,064 patients who were newly diagnosed with insomnia between January 1, 2010, and December 31, 2019. A pair of 3912 hypnotic users and nonusers were selected based on a 1:1 propensity score methodology. The primary outcome was extended major adverse cardiovascular events, a composite of the first occurrence of all-cause mortality or nonfatal major adverse cardiovascular events. RESULTS: During the median follow-up of 4.8 years, a total of 2791 composite events occurred, including 2033 deaths and 762 nonfatal major adverse cardiovascular events. Although the incidence rates of major adverse cardiovascular events were comparable between hypnotic users and nonusers in the propensity-matched cohort, users of benzodiazepines and Z-drugs had a higher risk of all-cause mortality (hazard ratio 1.47 [95% CI, 1.17-1.88] and 1.20 [95% CI, 1.03-1.39], respectively), while serotonin antagonist and reuptake inhibitors users had a survival advantage (hazard ratio 0.79 [95% CI, 0.69-0.91]) compared with nonusers. There were no differences in the risk of nonfatal major adverse cardiovascular events between all classes of hypnotics. Male patients and those aged 60 years or younger who were using benzodiazepines or Z-drugs experienced higher major adverse cardiovascular events than their counterparts. CONCLUSIONS: In patients with newly diagnosed insomnia, treatment with hypnotics resulted in higher extended major adverse cardiovascular events but not nonfatal major adverse cardiovascular events with benzodiazepine and Z-drug users compared with nonusers. The use of serotonin antagonist and reuptake inhibitors agents had a protective effect against major adverse cardiovascular events warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersHypnotics and SedativesCardiovascular DiseasesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedUnited StatesVeteransPropensity ScoreBenzodiazepinesRisk FactorsUnited States Department of Veterans Affairs

Stichwörter der Autor:innen

BenzodiazepinesCardiovascular eventsHypnoticsInsomniaTrazodoneZ-drugs

Substanzen

Hypnotics and SedativesBenzodiazepines

Autor:innen und Institutionen

  • The Veterans Affairs Western New York Healthcare System, Western New York Respiratory Research Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Buffalo, NY, USA; Department of Medicine, Jacobs School of…
  • The Veterans Affairs Western New York Healthcare System, Western New York Respiratory Research Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Buffalo, NY, USA. Electronic address: Yolanda.lawson@va.go…
  • Department of Biostatistics; Jacobs School of Medicine and Biomedical Sciences and School of Public Health and Health Professions, Buffalo, CY, USA. Electronic address: gwilding@buffalo.edu.

Förderung

  • CSRD VA
  • Office of Research and Development
  • Health Services Research and Development
  • US Department of Veterans Affairs
  • Clinical Science Research and Development

Zitieren

APA

El-Solh, A. A., Lawson, Y., & Wilding, G. E. (2023). The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia. Sleep Health. https://doi.org/10.1016/j.sleh.2023.05.006

Vancouver

El-Solh AA, Lawson Y, Wilding GE. The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia. Sleep Health. 2023. doi:10.1016/j.sleh.2023.05.006

BibTeX
@article{ElSolh2023,
  author = {El-Solh, Ali A and Lawson, Yolanda and Wilding, Gregory E},
  title = {The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia},
  journal = {Sleep Health},
  year = {2023},
  doi = {10.1016/j.sleh.2023.05.006}
}
Kostenlos starten →